Apr 28, 2023
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Apr. 28, 2023-- 2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, will announce its first quarter 2023 financial results on Wednesday, May 3, 2023 . 2seventy bio will host a conference call and webcast at 4:30 p.m.
Mar 08, 2023
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Mar. 8, 2023-- 2seventy bio, Inc. (Nasdaq: TSVT) today announced the appointment of Wei Lin , M.D. to the company’s Board of Directors, effective immediately. “We are thrilled to welcome Dr. Wei Lin to 2seventy’s Board during an exciting time in our Company’s
Mar 03, 2023
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Mar. 3, 2023-- 2seventy bio, Inc . (Nasdaq: TSVT) announced today that members of the management team will present at the 43rd Annual TD Cowen Health Care Conference at the Boston Marriott Copley Place in Boston, MA on March 7, 2023 at 10:30am ET .
Feb 28, 2023
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 28, 2023-- 2seventy bio, Inc. (“2seventy bio”) (Nasdaq: TSVT), a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer, announced today the pricing of a follow on underwritten public